Detalles de la búsqueda
1.
Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy.
Antimicrob Agents Chemother
; 60(4): 2248-56, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833162
2.
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.
Antimicrob Agents Chemother
; 59(2): 960-71, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25421485
3.
Analysis of the history and spread of HIV-1 in Uganda using phylodynamics.
J Gen Virol
; 96(Pt 7): 1890-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724670
4.
Human immunodeficiency virus Tat associates with a specific set of cellular RNAs.
Retrovirology
; 11: 53, 2014 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24990269
5.
Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1.
J Gen Virol
; 95(Pt 1): 190-200, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24172906
6.
Host-pathogen interaction in invasive Salmonellosis.
PLoS Pathog
; 8(10): e1002933, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23055923
7.
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.
J Antimicrob Chemother
; 68(10): 2339-43, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23711895
8.
Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144.
Viruses
; 15(6)2023 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37376649
9.
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
Open Forum Infect Dis
; 10(11): ofad526, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033982
10.
Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging.
Pharmaceuticals (Basel)
; 15(5)2022 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35631413
11.
The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.
Retrovirology
; 8: 31, 2011 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21569325
12.
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacity.
Antimicrob Agents Chemother
; 55(3): 1106-13, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21149628
13.
Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.
Antimicrob Agents Chemother
; 55(4): 1806-9, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21282419
14.
Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1.
J Virol
; 83(18): 9094-101, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19587031
15.
Activation of coagulation and endothelium with concurrent impairment of anticoagulant mechanisms in patients with typhoid fever.
J Infect
; 77(1): 60-67, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746945
16.
Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
PLoS One
; 11(6): e0157094, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27254277
17.
Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors.
AIDS Res Hum Retroviruses
; 31(7): 749-56, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25953118
18.
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
PLoS One
; 10(9): e0137834, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26382239
19.
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
PLoS One
; 10(12): e0145536, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700639
20.
Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study.
PLoS One
; 9(8): e106118, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25170963